20162019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
Review article

Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia

EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Jul 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1470-1486 17 p.

Research output: Contribution to journalReview article

Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia

for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Jul 1 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1470-1486 17 p.

Research output: Contribution to journalReview article

Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders

EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Jul 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1557-1566 10 p.

Research output: Contribution to journalReview article

Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders

for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Jul 1 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1557-1566 10 p.

Research output: Contribution to journalReview article

Clinical utility of FDG-PET for the clinical diagnosis in MCI

EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Jul 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1497-1508 12 p.

Research output: Contribution to journalReview article

Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia

EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Jul 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1509-1525 17 p.

Research output: Contribution to journalReview article

Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease

EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Jul 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1546-1556 11 p.

Research output: Contribution to journalReview article

Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia

EANM-EAN Task Force for the recommendation of FDG PET for Dementing Neurodegenerative Disorders, Jul 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1534-1545 12 p.

Research output: Contribution to journalReview article

Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease

EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Jul 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1487-1496 10 p.

Research output: Contribution to journalReview article